The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

The Globe and Mail has
updated our Stock Quote Pages
You are about to experience the newly designed Stock Quote Pages format. With the new layout, you'll enjoy a more in-depth look at the companies you're following and pages that are easier to navigate. This Editors' blog post explains why we've made these changes.

Knight Therapeutics Inc crosses above 200-day moving average

Knight Therapeutics Inc closed up Thursday by $0.09 or 1.22% to $7.45 and crossing above its 200-day moving average. Shares have lost 3.37% over the last five days, but have gained 7.66% over the last year to date. This security has outperformed the S&P TSX by 52.02% during the last year.

Key company metrics

  • Trailing P/E4.27×
  • P/E 1 year forward44.08×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$1.74
Updated July 30 4:00 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Fiscal Quarter Endvalues in $ millions unless otherwise notedMar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014Jun 30, 201406/30/2014
Total other revenue--------
Total revenue0000
Gross profit0------
Total cost of revenue0------
Total operating expense-14321
Selling / general / administrative3211
Research & development0010
Depreciation / amortization0000
Interest expense (income), net operating0------
Unusual expense (income)-8------
Other operating expenses, total0000
Operating income14-2-20
Interest income (expense), net non-operating--000
Gain (loss) on sale of assets--129----
Income before tax1413010
Income after tax1412510
Income tax, total0500
Net income1412510
Total adjustments to net income--------
Net income before extra. items1412510
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1412510
Inc. avail. to common incl. extra. items1412510
Diluted net income1412510
Dilution adjustment0------
Diluted weighted average shares93797863
Diluted EPS excluding extraordinary itemsvalue per share0.151.570.010.01
Dividends per sharevalue per share0.
Diluted normalized EPSvalue per share0.